statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Amedisys price target raised by $3 at RBC Capital, here's why

In a report released today, Gary Taylor from TD Cowen maintained a Hold rating on Amedisys (AMED Research Report), with a price target of $101.00...

A Balanced View: Growth and Challenges at Amedisys Amidst Pending Acquisition by UnitedHealth

Amedisys Non-GAAP EPS of $0.94 misses by $0.05, revenue of $570.8M misses by $0.83M...

Amedisys Non-GAAP EPS of $0.94 misses by $0.05, revenue of $570.8M misses by $0.83M

BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023. Three-Month...

Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results

Amedisys offers advanced molecular testing to care centers

BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular...

Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis

This price move could indicate a change in the trend, and may be a buy signal for investors...

Amedisys (AMED, $94.51) price moved above its 50-day Moving Average on February 02, 2024

Amedisys (AMED, $94.89) price moved above its 50-day Moving Average on January 26, 2024

This price move could indicate a change in the trend, and may be a sell signal for investors...

Amedisys (AMED, $94.3) price exceeded its 50-day Moving Average on January 25, 2024

This is a Bullish indicator signaling AMED's price could rise from here. Traders may explore going long the stock or buying call options...

Amedisys (AMED, $94.77) Moving Average Convergence Divergence (MACD) Histogram turned positive on January 19, 2024

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.

Volume	236,321.00
52-Wk High	$96.44
52-Wk Low	$73.10

AMED Amedisys Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals